T1	Participants 573 629	data from the Pirarubicin Monotherapy Study Group trial,
T2	Participants 1 143	ntravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial.
T3	Participants 437 554	further analysis of the Pirarubicin Monotherapy Study Group cohort, focusing on intravesical seeding of cancer cells.
